Logo image of ARCAD.AS

ARCADIS NV (ARCAD.AS) Stock Fundamental Analysis

AMS:ARCAD - Euronext Amsterdam - NL0006237562 - Common Stock - Currency: EUR

43.7  -0.1 (-0.23%)

Fundamental Rating

5

Taking everything into account, ARCAD scores 5 out of 10 in our fundamental rating. ARCAD was compared to 34 industry peers in the Professional Services industry. While ARCAD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ARCAD is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year ARCAD was profitable.
In the past year ARCAD had a positive cash flow from operations.
In the past 5 years ARCAD has always been profitable.
Each year in the past 5 years ARCAD had a positive operating cash flow.
ARCAD.AS Yearly Net Income VS EBIT VS OCF VS FCFARCAD.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

1.2 Ratios

With a decent Return On Assets value of 6.22%, ARCAD is doing good in the industry, outperforming 67.65% of the companies in the same industry.
ARCAD's Return On Equity of 19.71% is fine compared to the rest of the industry. ARCAD outperforms 70.59% of its industry peers.
The Return On Invested Capital of ARCAD (11.91%) is better than 67.65% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ARCAD is in line with the industry average of 10.84%.
The last Return On Invested Capital (11.91%) for ARCAD is above the 3 year average (9.74%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.22%
ROE 19.71%
ROIC 11.91%
ROA(3y)4.63%
ROA(5y)4.14%
ROE(3y)15.99%
ROE(5y)13.31%
ROIC(3y)9.74%
ROIC(5y)9.75%
ARCAD.AS Yearly ROA, ROE, ROICARCAD.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

The Profit Margin of ARCAD (6.26%) is better than 70.59% of its industry peers.
In the last couple of years the Profit Margin of ARCAD has grown nicely.
ARCAD has a better Operating Margin (10.03%) than 70.59% of its industry peers.
ARCAD's Operating Margin has improved in the last couple of years.
Industry RankSector Rank
OM 10.03%
PM (TTM) 6.26%
GM N/A
OM growth 3Y5.13%
OM growth 5Y8.46%
PM growth 3Y-1.46%
PM growth 5Y67.33%
GM growth 3YN/A
GM growth 5YN/A
ARCAD.AS Yearly Profit, Operating, Gross MarginsARCAD.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8 10

More info and screens

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ARCAD is creating value.
Compared to 1 year ago, ARCAD has less shares outstanding
ARCAD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for ARCAD has been reduced compared to a year ago.
ARCAD.AS Yearly Shares OutstandingARCAD.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ARCAD.AS Yearly Total Debt VS Total AssetsARCAD.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

ARCAD has an Altman-Z score of 2.65. This is not the best score and indicates that ARCAD is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.65, ARCAD perfoms like the industry average, outperforming 47.06% of the companies in the same industry.
The Debt to FCF ratio of ARCAD is 3.66, which is a good value as it means it would take ARCAD, 3.66 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 3.66, ARCAD is doing good in the industry, outperforming 61.76% of the companies in the same industry.
ARCAD has a Debt/Equity ratio of 0.78. This is a neutral value indicating ARCAD is somewhat dependend on debt financing.
The Debt to Equity ratio of ARCAD (0.78) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 3.66
Altman-Z 2.65
ROIC/WACC1.8
WACC6.61%
ARCAD.AS Yearly LT Debt VS Equity VS FCFARCAD.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.22 indicates that ARCAD should not have too much problems paying its short term obligations.
ARCAD's Current ratio of 1.22 is fine compared to the rest of the industry. ARCAD outperforms 61.76% of its industry peers.
ARCAD has a Quick Ratio of 1.22. This is a normal value and indicates that ARCAD is financially healthy and should not expect problems in meeting its short term obligations.
ARCAD's Quick ratio of 1.22 is fine compared to the rest of the industry. ARCAD outperforms 67.65% of its industry peers.
Industry RankSector Rank
Current Ratio 1.22
Quick Ratio 1.22
ARCAD.AS Yearly Current Assets VS Current LiabilitesARCAD.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

1

3. Growth

3.1 Past

ARCAD shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.36%.
ARCAD shows a small growth in Revenue. In the last year, the Revenue has grown by 0.76%.
EPS 1Y (TTM)3.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)0.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.41%

3.2 Future

ARCAD is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.28% yearly.
The Revenue is expected to grow by 4.52% on average over the next years.
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%

3.3 Evolution

ARCAD.AS Yearly Revenue VS EstimatesARCAD.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
ARCAD.AS Yearly EPS VS EstimatesARCAD.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4 5

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 28.38, ARCAD can be considered very expensive at the moment.
ARCAD's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.34, ARCAD is valued at the same level.
Based on the Price/Forward Earnings ratio of 25.43, the valuation of ARCAD can be described as expensive.
ARCAD's Price/Forward Earnings ratio is in line with the industry average.
ARCAD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.38
Fwd PE 25.43
ARCAD.AS Price Earnings VS Forward Price EarningsARCAD.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ARCAD is valued a bit cheaper than the industry average as 67.65% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ARCAD indicates a somewhat cheap valuation: ARCAD is cheaper than 67.65% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.96
EV/EBITDA 8.78
ARCAD.AS Per share dataARCAD.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of ARCAD may justify a higher PE ratio.
A cheap valuation may be justified as ARCAD's earnings are expected to decrease with -7.26% in the coming years.
PEG (NY)2.92
PEG (5Y)N/A
EPS Next 2Y5.64%
EPS Next 3Y-7.26%

More info and screens

5

5. Dividend

5.1 Amount

ARCAD has a Yearly Dividend Yield of 2.22%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.95, ARCAD pays a bit more dividend than its industry peers.
ARCAD's Dividend Yield is comparable with the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 2.22%

5.2 History

The dividend of ARCAD is nicely growing with an annual growth rate of 31.53%!
Dividend Growth(5Y)31.53%
Div Incr Years6
Div Non Decr Years6
ARCAD.AS Yearly Dividends per shareARCAD.AS Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

31.28% of the earnings are spent on dividend by ARCAD. This is a low number and sustainable payout ratio.
DP31.28%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
ARCAD.AS Yearly Income VS Free CF VS DividendARCAD.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M
ARCAD.AS Dividend Payout.ARCAD.AS Dividend Payout, showing the Payout Ratio.ARCAD.AS Dividend Payout.PayoutRetained Earnings

More info and screens

ARCADIS NV

AMS:ARCAD (6/18/2025, 7:00:00 PM)

43.7

-0.1 (-0.23%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)05-07 2025-05-07
Earnings (Next)07-31 2025-07-31
Inst Owners50.15%
Inst Owner ChangeN/A
Ins Owners0.46%
Ins Owner ChangeN/A
Market Cap3.95B
Analysts81.11
Price Target63.86 (46.13%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.22%
Yearly Dividend0.85
Dividend Growth(5Y)31.53%
DP31.28%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.43%
Min Revenue beat(2)-4.47%
Max Revenue beat(2)-4.39%
Revenue beat(4)0
Avg Revenue beat(4)-11.32%
Min Revenue beat(4)-30.71%
Max Revenue beat(4)-4.39%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.93%
PT rev (3m)-12.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-4.61%
Revenue NQ rev (1m)-3.21%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.57%
Valuation
Industry RankSector Rank
PE 28.38
Fwd PE 25.43
P/S 1.02
P/FCF 12.96
P/OCF 11.29
P/B 3.21
P/tB N/A
EV/EBITDA 8.78
EPS(TTM)1.54
EY3.52%
EPS(NY)1.72
Fwd EY3.93%
FCF(TTM)3.37
FCFY7.72%
OCF(TTM)3.87
OCFY8.86%
SpS42.9
BVpS13.63
TBVpS-3.02
PEG (NY)2.92
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.22%
ROE 19.71%
ROCE 16.66%
ROIC 11.91%
ROICexc 14.06%
ROICexgc 58.82%
OM 10.03%
PM (TTM) 6.26%
GM N/A
FCFM 7.86%
ROA(3y)4.63%
ROA(5y)4.14%
ROE(3y)15.99%
ROE(5y)13.31%
ROIC(3y)9.74%
ROIC(5y)9.75%
ROICexc(3y)11.24%
ROICexc(5y)11.87%
ROICexgc(3y)46.91%
ROICexgc(5y)45.96%
ROCE(3y)13.66%
ROCE(5y)13.67%
ROICexcg growth 3Y8.93%
ROICexcg growth 5Y-10.74%
ROICexc growth 3Y2.55%
ROICexc growth 5Y6.48%
OM growth 3Y5.13%
OM growth 5Y8.46%
PM growth 3Y-1.46%
PM growth 5Y67.33%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 3.66
Debt/EBITDA 1.82
Cap/Depr 32.14%
Cap/Sales 1.16%
Interest Coverage 7.48
Cash Conversion 66.16%
Profit Quality 125.51%
Current Ratio 1.22
Quick Ratio 1.22
Altman-Z 2.65
F-Score8
WACC6.61%
ROIC/WACC1.8
Cap/Depr(3y)29.56%
Cap/Depr(5y)27.6%
Cap/Sales(3y)1.19%
Cap/Sales(5y)1.19%
Profit Quality(3y)159.52%
Profit Quality(5y)558.67%
High Growth Momentum
Growth
EPS 1Y (TTM)3.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y9.71%
EPS Next 2Y5.64%
EPS Next 3Y-7.26%
EPS Next 5Y-5.28%
Revenue 1Y (TTM)0.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%0.41%
Revenue Next Year1.48%
Revenue Next 2Y15.79%
Revenue Next 3Y8.76%
Revenue Next 5Y4.52%
EBIT growth 1Y42.73%
EBIT growth 3Y20.69%
EBIT growth 5Y17.72%
EBIT Next Year45.49%
EBIT Next 3Y20.21%
EBIT Next 5YN/A
FCF growth 1Y13.74%
FCF growth 3Y1.15%
FCF growth 5Y12.49%
OCF growth 1Y13.37%
OCF growth 3Y2.04%
OCF growth 5Y9.96%